Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

What's New in Aquablation.

Richard Lee1, Claus Roehrborn2

  • 1James Buchanan Brady Foundation, Department of Urology, Weill Medical College of Cornell University, New York, NY, USA.

European Urology Focus
|May 12, 2018
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Predictors of durability of the prostatic urethral lift (PUL) for benign prostatic hyperplasia.

Prostate cancer and prostatic diseases·2026
Same author

Real-World Treatment Outcomes in Patients With Ga68-PSMA-PET Positive Metastatic Hormone-Sensitive Prostate Cancer With or Without Conventional Imaging Correlates.

Clinical genitourinary cancer·2025
Same author

Improving Patient Selection for BPH Medical and Surgical Therapy Through a Deeper Understanding of Prostate Cellular and Molecular Biology.

The Urologic clinics of North America·2025
Same author

Relative Impact of Male Urinary Conditions on Overall Quality of Life.

Neurourology and urodynamics·2025
Same author

Correction: Extended LUTS medication use following BPH surgical treatment: a US healthcare claims analysis.

Prostate cancer and prostatic diseases·2025
Same author

Extended LUTS medication use following BPH surgical treatment: a US healthcare claims analysis.

Prostate cancer and prostatic diseases·2025
Same journal

Self-management of Male LUTS.

European urology focus·2026
Same journal

Transperineal Versus Transrectal Magnetic Resonance Imaging-targeted Prostate Biopsy in the Era of Lesion-focused Sampling.

European urology focus·2026
Same journal

Should Male Pattern Baldness Be Considered in Prostate Cancer Risk Assessment? A Systematic Review and Meta-analysis.

European urology focus·2026
Same journal

A Core Outcome Set for Localized Renal Cell Cancer (L-RCC-COS).

European urology focus·2026
Same journal

Reply to Emre Karabay's Letter to the Editor re: Ritter Manuel, Stein Johannes, Barber Neil, et al. WATER III: A Prospective, Partially Randomized Trial of Aquablation Therapy Versus Transurethral Laser Enucleation of the Prostate for Treatment of Lower Urinary Tract Symptoms. Eur Urol Focus 2026;12:266-74.

European urology focus·2026
Same journal

Radioligand Therapy for Prostate Cancer - A Clinical Consultation Guide.

European urology focus·2026
See all related articles

The Aquabeam system offers a promising alternative to transurethral resection of the prostate (TURP) for benign prostatic hyperplasia, showing good short-term results and low complication rates.

Area of Science:

  • Urology
  • Minimally Invasive Surgery
  • Medical Device Technology

Background:

  • Transurethral resection of the prostate (TURP) is the standard treatment for benign prostatic enlargement (BPE) with lower urinary tract symptoms (LUTS).
  • TURP, while effective, has risks including bleeding, infection, and dilutional hyponatremia.
  • New technologies are needed to improve safety and efficacy in BPE treatment.

Purpose of the Study:

  • To review early clinical experiences with the Aquabeam system for treating benign prostatic enlargement.
  • To evaluate the safety and short-term effectiveness of Aquabeam compared to traditional TURP.

Main Methods:

  • The Aquabeam system utilizes robotically controlled high-velocity water jets for prostatic tissue ablation.
  • Real-time ultrasound guidance is employed during the procedure.
Keywords:
Ablation techniquesMinimally invasive surgical proceduresProstatic hyperplasiaTransurethral resection of the prostateWater

Related Experiment Videos

  • Hemostasis is achieved using a catheter balloon tamponade, a novel traction device, or electrocautery.

    • Main Results:

    • Early clinical data suggest promising short-term outcomes for the Aquabeam system.
    • Significant improvements in urinary symptoms and patient bother were observed.
    • Operative times were comparable to TURP, with a low rate of surgical complications.

    Conclusions:

    • The Aquabeam system demonstrates favorable short-term efficacy and safety for treating BPE.
    • Further research is necessary to establish the long-term effectiveness of this novel technology.